Literature DB >> 9933465

A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.

S Kumaki1, H D Ochs, K K Kuropatwinski, T Konno, M S Timour, D Cosman, H Baumann.   

Abstract

Mutations of the common gamma (gammac) chain result in X-linked SCID (X-SCID), which is characterized by the reduction in number or absence of peripheral blood T cells and natural killer (NK) cells, with retention of normal numbers of B cells. In the present study we describe a novel mutant gammac chain of an X-SCID patient with a typical X-SCID phenotype. This mutant receptor subunit is able to associate with Jak3 to transduce a weak signal. The Jak3-specific action is demonstrated by the induction of gene expression through the haematopoietin receptor response element (HRRE) by IL-2 and IL-4 in the experimental model of transiently transfected hepatoma cells over-expressing Jak3. This result suggests that a threshold in the gammac-Jak3 interaction determines the X-SCID phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933465      PMCID: PMC1905160          DOI: 10.1046/j.1365-2249.1999.00792.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood.

Authors:  N Ishii; T Takeshita; Y Kimura; K Tada; M Kondo; M Nakamura; K Sugamura
Journal:  Int Immunol       Date:  1994-08       Impact factor: 4.823

2.  Cloning of the gamma chain of the human IL-2 receptor.

Authors:  T Takeshita; H Asao; K Ohtani; N Ishii; S Kumaki; N Tanaka; H Munakata; M Nakamura; K Sugamura
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

3.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

Authors:  X Cao; E W Shores; J Hu-Li; M R Anver; B L Kelsall; S M Russell; J Drago; M Noguchi; A Grinberg; E T Bloom
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

4.  The action of interleukin-2 receptor subunits defines a new type of signaling mechanism for hematopoietin receptors in hepatic cells and fibroblasts.

Authors:  K K Morella; C F Lai; S Kumaki; N Kumaki; Y Wang; E M Bluman; B A Witthuhn; J N Ihle; J Giri; D P Gearing
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

5.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.

Authors:  T Miyazaki; A Kawahara; H Fujii; Y Nakagawa; Y Minami; Z J Liu; I Oishi; O Silvennoinen; B A Witthuhn; J N Ihle
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

6.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.

Authors:  S M Russell; J A Johnston; M Noguchi; M Kawamura; C M Bacon; M Friedmann; M Berg; D W McVicar; B A Witthuhn; O Silvennoinen
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

7.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

Authors:  J P DiSanto; W Müller; D Guy-Grand; A Fischer; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

8.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

9.  Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently.

Authors:  S Kumaki; H D Ochs; M Timour; K Schooley; M Ahdieh; H Hill; K Sugamura; D Anderson; Q Zhu; D Cosman
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Authors:  S M Russell; N Tayebi; H Nakajima; M C Riedy; J L Roberts; M J Aman; T S Migone; M Noguchi; M L Markert; R H Buckley; J J O'Shea; W J Leonard
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  3 in total

Review 1.  Interleukin-2 signaling and inherited immunodeficiency.

Authors:  N A Cacalano; J A Johnston
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.

Authors:  Wenjun Mou; Jianxin He; Xi Chen; Hui Zhang; Xiaoya Ren; Xunyao Wu; Xin Ni; Baoping Xu; Jingang Gui
Journal:  Immunogenetics       Date:  2016-08-26       Impact factor: 2.846

3.  IL2RG hypomorphic mutation: identification of a novel pathogenic mutation in exon 8 and a review of the literature.

Authors:  Che Kang Lim; Hassan Abolhassani; Sofia K Appelberg; Mikael Sundin; Lennart Hammarström
Journal:  Allergy Asthma Clin Immunol       Date:  2019-01-05       Impact factor: 3.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.